Results 161 to 170 of about 33,145 (233)

Mechanisms of Oncolytic Virus-Induced Multi-Modal Cell Death and Therapeutic Prospects. [PDF]

Int J Mol Sci
Xu J, Liu C, An Y, Sun J, Wang S, Xia Q.
europepmc   +1 more source

A Multi-Omics Dataset of Prostate Cancer Response to Oncolytic Virus OH2 Treatment. [PDF]

Sci Data
Xu J, Ye G, An Y, Sun J, Liu C, Wang S, Xia Q.   +6 more
europepmc   +1 more source

Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors. [PDF]

J Immunother Cancer
Villano JL, Luke JJ, Julian R, Fountzilas C, Patel MR, Chisamore MJ, Bhattacharya P, Takeshita S, Soukharev S, Yamada S, Zhang L, Wentzel KP.   +11 more
europepmc   +1 more source

Enhanced oral nanomedicine utilizing biomineralized oncolytic virus for synergistic gastrointestinal cancer therapy. [PDF]

Mater Today Bio
Hu Z, Sun Y, Yu S, Zheng F, Yan Z, Lu N, Ye L, Yuan S, Zhu Y, Deng J, Wang J, Bai Y.   +11 more
europepmc   +1 more source

Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1. [PDF]

Adv Sci (Weinh)
Hu L, Zhang G, Lin Y, Yi S, Yang J, Lin X, Song D, Liu Z, Zhang J, Zeng Y, Huang S, Fan Z, Zhang J, Liu Y, Hu C, Zhu W, Yin W, Hu J, Yan G, Cai J, Liang J.   +20 more
europepmc   +1 more source

Opportunities, challenges, and future perspectives of oncolytic virus therapy for malignant melanoma. [PDF]

Front Immunol
Wang JW, Feng Q, Liu JH, Xun JJ.
europepmc   +1 more source

Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration. [PDF]

Cancers (Basel)
Sarkisova VA, Dalina AA, Neymysheva DO, Zenov MA, Ilyinskaya GV, Chumakov PM.   +5 more
europepmc   +1 more source

Oncolytic virus VG161 offers new hope for refractory liver cancer. [PDF]

Front Oncol
Li J, Zhou H, Wang X, Huang K, Wang Y.
europepmc   +1 more source

Efficacy, Safety and Predictive Biomarkers of Oncolytic Virus Therapy in Solid Tumors: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
El-Tanani M, Rabbani SA, Patni MA, Babiker R, Satyam SM, Rangraze IR, Wali AF, El-Tanani Y, Porntaveetus T.   +8 more
europepmc   +1 more source

Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levels. [PDF]

Mol Ther Oncol
Dryja P, Flores EB, Bartee MY, Palanisamy V, Bartee E.   +4 more
europepmc   +1 more source